However, a recent study by Shen et al. [43] showed that A3B was upregulated in peripheral blood mononuclear cells in severe and moderate COVID-19 patients, and that overexpression of exogenous A3B promoted SARS-CoV-2 pseudovirus infectivity. This evidence concerns the gene APOBEC3B and COVID-19.